Christopher S Lim1,2,3, Nicola Schieda1,2,3, Stuart G Silverman1,2,3. 1. 1 Department of Medical Imaging, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Ave, MG-175a, Toronto, ON M4N 3M5, Canada. 2. 2 Department of Radiology, The Ottawa Hospital, The University of Ottawa, Ottawa, ON, Canada. 3. 3 Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Abstract
OBJECTIVE: The objective of this article is to review the burgeoning role of percutaneous renal mass biopsy (RMB). CONCLUSION: Percutaneous RMB is safe, accurate, and indicated for an expanded list of clinical scenarios. The chief scenarios among them are to prevent treatment of benign masses and help select patients for active surveillance (AS). Imaging characterization of renal masses has improved; however, management decisions often depend on a histologic diagnosis and an assessment of biologic behavior of renal cancers, both of which are currently best achieved with RMB.
OBJECTIVE: The objective of this article is to review the burgeoning role of percutaneous renal mass biopsy (RMB). CONCLUSION: Percutaneous RMB is safe, accurate, and indicated for an expanded list of clinical scenarios. The chief scenarios among them are to prevent treatment of benign masses and help select patients for active surveillance (AS). Imaging characterization of renal masses has improved; however, management decisions often depend on a histologic diagnosis and an assessment of biologic behavior of renal cancers, both of which are currently best achieved with RMB.
Authors: Blanca Paño; Alexandre Soler; Debra A Goldman; Rafael Salvador; Laura Buñesch; Carmen Sebastià; Carlos Nicolau Journal: Br J Radiol Date: 2020-08-26 Impact factor: 3.039
Authors: Satheesh Krishna; Nicola Schieda; Ivan Pedrosa; Nicole Hindman; Ronaldo H Baroni; Stuart G Silverman; Matthew S Davenport Journal: J Magn Reson Imaging Date: 2020-10-02 Impact factor: 4.813